Inflammatory networks between adipose tissue, liver and pancreatic islets in type 2 diabetes.
7 affiliations
- 1CBIOS, ECTS, Lusófona University, Lisbon, Portugal.
- 2Universidad de Alcalá, Escuela de Doctorado, Madrid, Spain.
- 3Research & Early Development, Dompé Farmaceutici S.p.A, Naples, Italy.
- 4Independent Researcher, Milan, Italy.
- 5Department of Food Bioprocessing and Nutrition Sciences, Plants for Human Health Institute, North Carolina State University, Raleigh, NC, USA.
- 6CBIOS, ECTS, Lusófona University, Lisbon, Portugal. [email protected].
- 7Research & Early Development, Dompé Farmaceutici S.p.A, Naples, Italy. [email protected].
Abstract
Type 2 diabetes mellitus (T2D) is no longer viewed solely as a metabolic disorder but rather as a chronic, low-grade inflammatory disease shaped by the interplay of immune signaling and metabolic stress across key organs. This study explored inflammatory molecular signatures in pancreatic islets, adipose tissue (AT), and liver associated with T2D. Publicly available human genomic and transcriptomic datasets were identified through a PubMed search. Differentially expressed genes and all identified non-coding RNAs (ncRNAs) from the three tissues were subjected to bioinformatic and enrichment analyses to identify tissue-specific and common inflammatory mediators. Through integrative multi-omics and functional analyses, we delineated both shared and tissue-specific inflammatory circuits in pancreatic islets, liver, and AT, highlighting the convergence of cytokine networks, particularly TNF-α, IL-6 and IL-17, as potential mediators of inter-organ dysfunction. These cytokines can contribute to a pathological feedback loop whereby inflammatory cues originating in AT propagate to pancreatic and hepatic compartments, compounding insulin resistance and β-cell failure. AKT1, MAPK3, and CCL2 may represent key cross-tissue effectors linking inflammatory signaling and metabolic control, whose activity is also sensitive to age-related molecular drift and stress response imbalances. Additionally, ncRNAs such as miR-3064 and miR-21 emerged as potential key post-transcriptional regulators of NF-κB, IL-6 and IL-17 signaling pathways, supporting the notion that epigenetic and transcriptomic reprogramming is involved in metabolic inflammation. Overall, our findings suggest a multi-layered inflammatory architecture underlying T2D, highlighting inflammatory mediators and regulatory RNAs as potential targets for precision therapeutic strategies.
Related
- Micro-fragmented adipose tissue reprogrammes the systemic molecular landscape of inflammatory knee osteoarthritis
- The anti-inflammatory and bioregulatory effects of habitual exercise in high-fat diet-induced obesity involve crown-like structures and MCP-1 in white adipose tissue.
- Epicardial adipose tissue radiomics complement calcium scoring in black adults with type 2 diabetes mellitus
- Prometheus’s Fire, Part II: The Hydra of Inflammation—Multiorgan Self-Amplifying Inflammatory Loops in Obesity: Molecular Crosstalk Between Adipose Tissue, Liver, Skeletal Muscle, Pancreas and Cardiovascular System
- Cold Stress-Induced Adipose Tissue Remodeling in Min pigs: Involvement of the ADRB3-ERK Axis, Autophagy, and Inflammatory Pathways
BibTeX
@article{farrim2026inflammatory,
title = {{Inflammatory networks between adipose tissue, liver and pancreatic islets in type 2 diabetes.}},
author = {Maria Inês Farrim and Diogo Silva and Andreia Gomes and Lidia De Filippis and Georgia Fousteri and Andrea Aramini and Marcello Allegretti and Dragan Milenkovic and Regina Menezes and Rafael Cypriano Dutra},
journal = {Human genomics},
year = {2026},
month = aug,
doi = {10.1186/s40246-026-01016-8},
url = {https://europepmc.org/article/MED/42958439},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Inflammatory networks between adipose tissue, liver and pancreatic islets in type 2 diabetes.
AU - Maria Inês Farrim
AU - Diogo Silva
AU - Andreia Gomes
AU - Lidia De Filippis
AU - Georgia Fousteri
AU - Andrea Aramini
AU - Marcello Allegretti
AU - Dragan Milenkovic
AU - Regina Menezes
AU - Rafael Cypriano Dutra
PY - 2026
DA - 2026/08/03
JO - Human genomics
DO - 10.1186/s40246-026-01016-8
UR - https://europepmc.org/article/MED/42958439
AB - Type 2 diabetes mellitus (T2D) is no longer viewed solely as a metabolic disorder but rather as a chronic, low-grade inflammatory disease shaped by the interplay of immune signaling and metabolic stress across key organs. This study explored inflammatory molecular signatures in pancreatic islets, adipose tissue (AT), and liver associated with T2D. Publicly available human genomic and transcriptomic datasets were identified through a PubMed search. Differentially expressed genes and all identified non-coding RNAs (ncRNAs) from the three tissues were subjected to bioinformatic and enrichment analyses to identify tissue-specific and common inflammatory mediators. Through integrative multi-omics and functional analyses, we delineated both shared and tissue-specific inflammatory circuits in pancreatic islets, liver, and AT, highlighting the convergence of cytokine networks, particularly TNF-α, IL-6 and IL-17, as potential mediators of inter-organ dysfunction. These cytokines can contribute to a pathological feedback loop whereby inflammatory cues originating in AT propagate to pancreatic and hepatic compartments, compounding insulin resistance and β-cell failure. AKT1, MAPK3, and CCL2 may represent key cross-tissue effectors linking inflammatory signaling and metabolic control, whose activity is also sensitive to age-related molecular drift and stress response imbalances. Additionally, ncRNAs such as miR-3064 and miR-21 emerged as potential key post-transcriptional regulators of NF-κB, IL-6 and IL-17 signaling pathways, supporting the notion that epigenetic and transcriptomic reprogramming is involved in metabolic inflammation. Overall, our findings suggest a multi-layered inflammatory architecture underlying T2D, highlighting inflammatory mediators and regulatory RNAs as potential targets for precision therapeutic strategies.
SN - 1473-9542
SN - 1479-7364
ER -